Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

被引:93
|
作者
Tan, Sih Min [1 ]
Zhang, Yuan [1 ]
Connelly, Kim A. [1 ,3 ]
Gilbert, Richard E. [1 ,3 ]
Kelly, Darren J. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] St Vincents Inst Med Res, Melbourne, Vic, Australia
[3] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
基金
英国医学研究理事会;
关键词
interstitial fibrosis; cardiac remodeling; heart failure; SMOOTH MUSCLE ACTIN; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; FIBROSIS; TISSUE; INJURY; HEART; MYOFIBROBLASTS; HYPERTROPHY; TRANSITION;
D O I
10.1152/ajpheart.01048.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 298: H1415-H1425, 2010. First published February 12, 2010; doi:10.1152/ajpheart.01048.2009.-Following myocardial infarction (MI), the heart undergoes a pathological process known as remodeling, which in many instances results in cardiac dysfunction and ultimately heart failure and death. Transforming growth factor-beta (TGF-beta) is a key mediator in the pathogenesis of cardiac remodeling following MI. We thus aimed to inhibit TGF-beta signaling using a novel orally active TGF-beta type I receptor [activin receptor-like kinase 5 (ALK5)] inhibitor (GW788388) to attenuate left ventricular remodeling and cardiac dysfunction in a rat model of MI. Sprague-Dawley rats underwent left anterior descending coronary artery ligation to induce experimental MI and then were randomized to receive GW788388 at a dosage of 50 mg . kg(-1) . day(-1) or vehicle 1 wk after surgery. After 4 wk of treatment, echocardiography was performed before the rats were euthanized. Animals that received left anterior descending coronary artery ligation demonstrated systolic dysfunction, Smad2 activation, myofibroblasts accumulation, collagen deposition, and myocyte hypertrophy (all P < 0.05). Treatment with GW788388 significantly attenuated systolic dysfunction in the MI animals, together with the attenuation of the activated (phosphorylated) Smad2 (P < 0.01), alpha-smooth muscle actin (P < 0.001), and collagen I (P < 0.05) in the noninfarct zone of MI rats. Cardiomyocyte hypertrophy in MI hearts was also attenuated by ALK5 inhibition (P < 0.05). In brief, treatment with a novel TGF-beta type I receptor inhibitor, GW788388, significantly reduced TGF-beta activity, leading to the attenuation of systolic dysfunction and left ventricular remodeling in an experimental rat model of MI.
引用
收藏
页码:H1415 / H1425
页数:11
相关论文
共 50 条
  • [41] Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
    S. Levolger
    E. A. C. Wiemer
    J. L. A. van Vugt
    S. A. Huisman
    M. G. van Vledder
    S. van Damme-van Engel
    G. Ambagtsheer
    J. N. M. IJzermans
    R. W. F. de Bruin
    Scientific Reports, 9
  • [42] Inhibition of activin receptor-like kinase 5 induces matrix metallopeptidase 9 expression and aggravates lipopolysaccharide-induced pulmonary injury in mice
    Ma, B.
    Zhou, P. -Y.
    Ni, W.
    Wei, W.
    Ben, D. -F.
    Lu, W.
    Xia, Z. -F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (08) : 1051 - 1059
  • [43] Activin receptor-like kinase 4 deficiency attenuates atrial remodeling and vulnerability to atrial fibrillation induced by pressure overload in mice
    Wang, Qian
    Yu, Ying
    Chen, Yihe
    Li, Changyi
    Hou, Jianwen
    Li, Yigang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C47 - C48
  • [44] Suppression of Ocular Scarring After Glaucoma Filtration Surgery in Rabbits by Activin Receptor-Like Kinase 5 Inhibitor
    Sapitro, J.
    Dunmire, J. J.
    Sutariya, V.
    Geldenhuys, W. J.
    Hewit, M.
    Yue, B. Y. J. T.
    Nakamura, H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction
    Ni T.
    Huang X.
    Pan S.
    Lu Z.
    Oxidative Medicine and Cellular Longevity, 2021, 2021
  • [46] Flavones hydroxylated at 5, 7, 3′ and 4′ ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity
    Zhang, Yifan
    Wang, Jing
    Zhou, Sizheng
    Xie, Zhibo
    Wang, Chuandong
    Gao, Ya
    Zhou, Jia
    Zhang, Xiaoling
    Li, Qingfeng
    CELL DEATH & DISEASE, 2019, 10 (2)
  • [47] Flavones hydroxylated at 5, 7, 3′ and 4′ ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity
    Yifan Zhang
    Jing Wang
    Sizheng Zhou
    Zhibo Xie
    Chuandong Wang
    Ya Gao
    Jia Zhou
    Xiaoling Zhang
    Qingfeng Li
    Cell Death & Disease, 10
  • [48] An Activin Receptor-Like Kinase 5 Inhibitor Reduces Collagen Deposition in a Rat Dermal Incision Wound Healing Model
    Bian, Feng
    Render, James
    Ren, Xiao-Dan
    Chio, Christopher
    Chan, Kam
    Boys, Mark
    Lala, Deepak S.
    Pocalyko, David
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 128 (05) : 451E - 459E
  • [49] Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor
    Sapitro, Jennifer
    Dunmire, Jeffrey J.
    Scott, Sarah E.
    Sutariya, Vijay
    Geldenhuys, Werner J.
    Hewit, Michael
    Yue, Beatrice Y. J. T.
    Nakamura, Hiroshi
    MOLECULAR VISION, 2010, 16 (204-05): : 1880 - 1892
  • [50] Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery
    Sutariya, Vijaykumar
    Miladore, Nicholas
    Geldenhuys, Werner
    Bhatia, Deepak
    Wehrung, Daniel
    Nakamura, Hiroshi
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (04) : 957 - 962